About the Product

Description


Saxaplit M Tablet containing Saxagliptin and Metformin is used for the management of type 2 diabetes mellitus. It helps improve blood sugar control and supports better glycemic balance.

Saxagliptin works by increasing insulin release and reducing glucose production, while Metformin improves insulin sensitivity and reduces hepatic glucose output.

The tablet is widely prescribed in endocrinology and general medicine practice for long-term diabetes management, leading to consistent prescription demand.

With increasing prevalence of diabetes and metabolic disorders, this product offers strong business potential for retailers and distributors. Its dual mechanism of action, broad clinical relevance, and steady market demand make it a reliable product for growth in the anti-diabetic segment.

Some patients may experience nausea, diarrhea, abdominal discomfort, headache, upper respiratory tract infections, or hypoglycemia (when combined with other antidiabetics). Rarely, lactic acidosis or pancreatitis may occur and require immediate medical attention.

Saxaplit M Tablet is indicated for type 2 diabetes mellitus, especially in patients who are not adequately controlled on single therapy. It helps lower fasting and postprandial blood glucose levels, improve insulin response, and support long-term glycemic control.

This medicine should be used under medical supervision along with diet and exercise. Regular monitoring of blood glucose and kidney function is recommended. Avoid excessive alcohol intake while on Metformin-containing therapy.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Saxaplit M Tablet in the PCD pharma franchise market?

Saxaplit M Tablet, containing Saxagliptin 2.5mg and Metformin 500mg, has strong demand in the antidiabetic segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on diabetes management and metabolic disorder portfolios.

Why should medical distributors include Saxaplit M Tablet in their product range?

Medical distributors and agencies can benefit from the consistent demand for combination oral antidiabetic therapy used in type 2 diabetes mellitus. Metformin reduces hepatic glucose production, while Saxagliptin improves insulin response, strengthening a comprehensive diabetes care product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Saxaplit M Tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Saxaplit M Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for Saxaplit M Tablet distribution?

Wholesalers and medical agencies benefit from strong chronic diabetes prescription demand, long-term therapy usage, reliable supply chain support, and good margins when partnering for Saxaplit M Tablet distribution.

How can I become a distributor or franchise partner for Saxaplit M Tablet?

Medical distributors, stockists, and wholesalers interested in Saxaplit M Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.